Julie Olsson Selected Research

lebrikizumab

1/2021	Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis.
1/2019	Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthma.
1/2018	Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
10/2017	Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma.
1/2017	Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumab.
10/2016	Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.
8/2015	Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Olsson Research Topics

Disease

7	Asthma (Bronchial Asthma) 01/2019 - 08/2015
5	Inflammation (Inflammations) 09/2021 - 01/2014
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2021
1	Eosinophilia 01/2018
1	Airway Obstruction (Choking) 10/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2016
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 10/2016

Drug/Important Bio-Agent (IBA)

7	lebrikizumabIBA 01/2021 - 08/2015
4	Biomarkers (Surrogate Marker)IBA 09/2021 - 10/2016
4	Monoclonal AntibodiesIBA 01/2021 - 10/2016
3	PeriostinIBA 01/2018 - 08/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 08/2015
2	Interleukin-13IBA 01/2018 - 10/2017
1	lysophosphatidic acidIBA 09/2021
1	LipidsIBA 09/2021
1	Carbon MonoxideIBA 01/2021
1	InterleukinsIBA 01/2021
1	pirfenidoneIBA 01/2021
1	montelukast (Singulair)FDA Link 01/2018
1	Bronchodilator Agents (Bronchodilators)IBA 10/2016

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2014